Results 71 to 80 of about 15,470 (180)

PHEX gene and hypophosphatemia [PDF]

Kidney International, 2000
PHEX gene and hypophosphatemia. X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) are diseases that have in common abnormal proximal renal tubular function resulting in increased renal clearance of inorganic phosphorus and hypophosphatemia. The recent discovery of the PHEX gene has provided new insights to these disorders.
openaire   +2 more sources

Symptomatic Ferric Carboxymaltose‐Induced Hypophosphataemia: A Case Series of 11 Patients

eJHaem, Volume 7, Issue 4, August 2026.
Marina Weerheim, Heva Korevaar, Maurice Bizino, Gijs Fortrie, Loes Vrolijk, Ted Koster, Faiz Karim   +6 more
wiley   +1 more source

X-Linked Hypophosphatemia with Whole Aspects

Endocrinology Research and Practice
X-linked hypophosphatemia (XLH) is a rare genetic disorder caused by mutations in the PHEX gene, and it is a primary example of a genetic cause of hypophosphatemia.
Nergis Basmaci, Alper Gürlek
doaj   +1 more source

Abnormal serum phosphorus was associated with the outcome of community-acquired pneumonia

Frontiers in Nutrition
ObjectiveThe present study aimed to explore the relationship between serum phosphorus levels and outcomes in patients with community-acquired pneumonia (CAP).MethodsThis research was a retrospective, single-center study conducted on adult patients who ...
Si-Qiong Wang, Cui-Hua Ma, Chun-Ming Ma, Rui Wang   +3 more
doaj   +1 more source

FGF23, Hypophosphatemia, and Emerging Treatments

JBMR Plus, 2019
FGF23 is an important hormonal regulator of phosphate homeostasis. Together with its co‐receptor Klotho, it modulates phosphate reabsorption and both 1α‐hydroxylation and 24‐hydroxylation in the renal proximal tubules.
Erik A Imel, Andrew Biggin, Aaron Schindeler, Craig F Munns   +3 more
doaj   +1 more source

Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience

Acta Clinica Croatica
The aim of this study was to determine the frequency of hypophosphatemia in female patients with iron deficiency anemia (IDA) treated parenterally with ferric carboxymaltose (FCM).
Nikolina Brkić, Ivana Vučinić Ljubičić, Hrvoje Holik, Božena Coha   +3 more
doaj   +1 more source

Hypophosphatemia Due to Adefovir Treatment [PDF]

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2012
Adefovir dipivoxil is an orally effective prodrug excreted unchanged in urine by glomerular filtration and tubular secretion. While it effectively suppresses hepatitis B virus replication, it may cause nephrotoxicity characterized by severe ...
Nazlım AKTUĞ DEMİR, Servet KÖLGELİER, Serap ÖZÇİMEN, Selçuk AKSÖZ, Ahmet Çağkan İNKAYA   +4 more
doaj  

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose

JGH Open, 2019
Intravenous iron is commonly prescribed for treatment of iron deficiency, with modern formulations demonstrating an acceptable safety profile in the majority of patients.
Wendy Fang, Lawrence P McMahon, Stephen Bloom, Mayur Garg   +3 more
doaj   +1 more source

Incidence and Clinical Outcomes of Hypophosphatemia in Patients with Diabetic Ketoacidosis Admitted to a Tertiary Care Hospital

Pakistan Journal of Medicine and Dentistry
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by hyperglycemia, ketosis, and acidosis. Hypophosphatemia is a frequently overlooked yet clinically significant electrolyte disturbance during ...
Sadaf Abdullah, Subtain Hassan, Shifa Haleem, Tariq Ahmad, Umair Islam, Maryam Abdullah   +5 more
doaj   +1 more source

Acute hypophosphatemia [PDF]

Kidney International, 1982
openaire   +2 more sources